455 related articles for article (PubMed ID: 27917585)
21. Non-alcoholic fatty liver disease is not associated with a lower health perception.
Mlynarsky L; Schlesinger D; Lotan R; Webb M; Halpern Z; Santo E; Shibolet O; Zelber-Sagi S
World J Gastroenterol; 2016 May; 22(17):4362-72. PubMed ID: 27158205
[TBL] [Abstract][Full Text] [Related]
22. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
23. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
[TBL] [Abstract][Full Text] [Related]
24. Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
Yang S; Kwak S; Lee JH; Kang S; Lee SP
PLoS One; 2019; 14(11):e0224626. PubMed ID: 31682638
[TBL] [Abstract][Full Text] [Related]
25. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
[TBL] [Abstract][Full Text] [Related]
26. Effect of physical activity on the development and the resolution of nonalcoholic fatty liver in relation to body mass index.
Choi HI; Lee MY; Kim H; Oh BK; Lee SJ; Kang JG; Lee SH; Kim BJ; Kim BS; Kang JH; Lee JY; Sung KC
BMC Public Health; 2022 Apr; 22(1):655. PubMed ID: 35382785
[TBL] [Abstract][Full Text] [Related]
27. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
28. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
[TBL] [Abstract][Full Text] [Related]
29. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.
Baeg MK; Yoon SK; Ko SH; Noh YS; Lee IS; Choi MG
World J Gastroenterol; 2016 Feb; 22(8):2592-600. PubMed ID: 26937147
[TBL] [Abstract][Full Text] [Related]
31. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
[TBL] [Abstract][Full Text] [Related]
32. Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.
Jung HS; Chang Y; Kwon MJ; Sung E; Yun KE; Cho YK; Shin H; Ryu S
Am J Gastroenterol; 2019 Mar; 114(3):453-463. PubMed ID: 30353055
[TBL] [Abstract][Full Text] [Related]
33. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
[TBL] [Abstract][Full Text] [Related]
34. Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.
Yamazaki H; Tsuboya T; Tsuji K; Dohke M; Maguchi H
Diabetes Care; 2015 Sep; 38(9):1673-9. PubMed ID: 26156527
[TBL] [Abstract][Full Text] [Related]
35. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
[TBL] [Abstract][Full Text] [Related]
36. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.
Chang Y; Jung HS; Yun KE; Cho J; Cho YK; Ryu S
Am J Gastroenterol; 2013 Dec; 108(12):1861-8. PubMed ID: 24100261
[TBL] [Abstract][Full Text] [Related]
37. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease.
Ryu S; Chang Y; Jung HS; Yun KE; Kwon MJ; Choi Y; Kim CW; Cho J; Suh BS; Cho YK; Chung EC; Shin H; Kim YS
J Hepatol; 2015 Nov; 63(5):1229-37. PubMed ID: 26385766
[TBL] [Abstract][Full Text] [Related]
38. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
[TBL] [Abstract][Full Text] [Related]
39. Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study.
Zelber-Sagi S; Nitzan-Kaluski D; Goldsmith R; Webb M; Zvibel I; Goldiner I; Blendis L; Halpern Z; Oren R
Hepatology; 2008 Dec; 48(6):1791-8. PubMed ID: 18972405
[TBL] [Abstract][Full Text] [Related]
40. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
